Avalo Therapeutics, Inc. (AVTX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch AVTX
See up to 3 months of AVTX. The 7-day demo opens the 1M and 3M ranges and puts AVTX on your watchlist.
Start 7-day demoLatest AVTX insider trades
About Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. is an SEC registrant, filing under CIK 0001534120, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
AVTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 101,317 | $1.95M |
| Grant or award | 3 | 3,783 | |
| Option exercise | 18 | 195,578 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AVTX insider transactions (Form 4)
5868 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Rita Jain - Director | Grant or award | Stock Option (Right to Buy) | 1,322 | $12.29 footnote F2 | $16K | |
| ||||||
| Kevin Robert Lind - Director | Grant or award | Stock Option (Right to Buy) | 1,352 | $12.29 footnote F2 | $17K | |
| ||||||
 Ron M. Philip - Director | Grant or award | Stock Option (Right to Buy) | 1,109 | $12.29 footnote F2 | $14K | |
| ||||||
| Christopher Ryan Sullivan - Officer | Option exercise | Common Stock | 12,394 | $9.88 | $122K | |
| Christopher Ryan Sullivan - Officer | Open-market sale | Common Stock | 12,394 | $16.33 footnote F2 | $202K | |
| Christopher Ryan Sullivan - Officer | Option exercise | Stock Option (Right to Buy) | 12,394 | $0.00 | - | |
| ||||||
| Christopher Ryan Sullivan - Officer | Option exercise | Common Stock | 10,185 | $8.04 | $82K | |
| Christopher Ryan Sullivan - Officer | Open-market sale | Common Stock | 10,185 | $17.62 footnote F2 | $179K | |
| Christopher Ryan Sullivan - Officer | Option exercise | Stock Option (Right to Buy) | 10,185 | $0.00 | - | |
| ||||||
| Mittie Doyle - Officer | Option exercise | Common Stock | 679 | $8.04 | $5K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 679 | $20.00 | $14K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 679 | $0.00 | - | |
| Christopher Ryan Sullivan - Officer | Option exercise | Common Stock | 37,945 | $9.88 | $375K | |
| Christopher Ryan Sullivan - Officer | Option exercise | Common Stock | 2,876 | $9.88 | $28K | |
| Christopher Ryan Sullivan - Officer | Open-market sale | Common Stock | 37,945 | $19.85 footnote F2 | $753K | |
| Christopher Ryan Sullivan - Officer | Open-market sale | Common Stock | 3,749 | $19.94 footnote F3 | $75K | |
| Christopher Ryan Sullivan - Officer | Option exercise | Common Stock | 31,031 | $9.88 | $307K | |
| Christopher Ryan Sullivan - Officer | Open-market sale | Common Stock | 31,031 | $20.05 footnote F4 | $622K | |
| Christopher Ryan Sullivan - Officer | Option exercise | Stock Option (Right to Buy) | 37,945 | $0.00 | - | |
| Christopher Ryan Sullivan - Officer | Option exercise | Stock Option (Right to Buy) | 2,876 | $0.00 | - | |
| Christopher Ryan Sullivan - Officer | Option exercise | Stock Option (Right to Buy) | 31,031 | $0.00 | - | |
| ||||||
| Mittie Doyle - Officer | Option exercise | Common Stock | 1,000 | $12.65 | $13K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 1,000 | $20.00 | $20K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 1,000 | $0.00 | - | |
 Jennifer Riley - Officer | Open-market sale | Common Stock | 2,655 | $19.59 footnote F1 | $52K | |
| ||||||
| Mittie Doyle - Officer | Option exercise | Common Stock | 679 | $8.04 | $5K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 679 | $20.00 | $14K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 679 | $0.00 | - | |
| Mittie Doyle - Officer | Option exercise | Common Stock | 1,000 | $12.65 | $13K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 1,000 | $20.00 | $20K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 1,000 | $0.00 | - | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 2,875 | $0.00 | - | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 1,779 | $0.00 | - | |
| Mittie Doyle - Officer | Option exercise | Common Stock | 2,875 | $12.65 | $36K | |
| Mittie Doyle - Officer | Option exercise | Common Stock | 1,779 | $8.04 | $14K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 4,654 | $20.00 | $93K | |
| Ron M. Philip | Grant or award | Stock Option (Right to Buy) | 69 | $15.04 | $1K | |
| Kevin Robert Lind | Grant or award | Stock Option (Right to Buy) | 1,105 | $15.04 | $17K | |
| Rita Jain | Grant or award | Stock Option (Right to Buy) | 1,080 | $15.04 | $16K | |
| Mittie Doyle - Officer | Option exercise | Common Stock | 1,450 | $8.04 | $12K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 1,450 | $18.00 | $26K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 1,450 | $0.00 | - | |
| Ron M. Philip | Grant or award | Stock Option (Right to Buy) | 40,200 | $0.00 | - | |
| Jennifer Riley - Officer | Tax withholding / forfeiture | Common Stock | 588 | $13.10 | $8K | |
| Paul Varki - Officer | Tax withholding / forfeiture | Common Stock | 1,081 | $13.10 | $14K | |
| Christopher Ryan Sullivan - Officer | Tax withholding / forfeiture | Common Stock | 138 | $13.10 | $2K | |
| Mittie Doyle - Officer | Tax withholding / forfeiture | Common Stock | 1,084 | $13.10 | $14K | |
| Kevin Robert Lind | Grant or award | Stock Option (Right to Buy) | 20,100 | $0.00 | - | |
 Samantha Truex | Grant or award | Stock Option (Right to Buy) | 20,100 | $0.00 | - | |
| Gilla Kaplan | Grant or award | Stock Option (Right to Buy) | 20,100 | $0.00 | - | |
| Aaron Kantoff | Grant or award | Stock Option (Right to Buy) | 20,100 | $0.00 | - | |
 Michael Thomas Heffernan | Grant or award | Stock Option (Right to Buy) | 29,500 | $0.00 | - | |
| Rita Jain | Grant or award | Stock Option (Right to Buy) | 20,100 | $0.00 | - | |
| Mittie Doyle - Officer | Option exercise | Common Stock | 679 | $8.04 | $5K | |
| Mittie Doyle - Officer | Open-market sale | Common Stock | 679 | $16.00 | $11K | |
| Mittie Doyle - Officer | Option exercise | Stock Option (Right to Buy) | 679 | $0.00 | - | |
| Jennifer Riley - Officer | Grant or award | Common Stock | 34,200 | $0.00 | - | |
| Christopher Ryan Sullivan - Officer | Grant or award | Common Stock | 39,900 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02
Item 8.01, 9.01
Item 3.02, 3.03, 5.02, 5.03, 9.01
Recent AVTX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| CHRISTOPHER RYAN SULLIVAN | Officer | 31,031 | $622K | View on EDGAR | |
| CHRISTOPHER RYAN SULLIVAN | Officer | 3,749 |
AVTX insider trading FAQ
What is the latest insider trade for AVTX?
Avalo Therapeutics, Inc. (AVTX) had 11 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for AVTX runs to 68 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AVTX stock?
No insider purchases of AVTX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling AVTX stock?
10 insider sales of AVTX were filed in the last 90 days, totaling $1.95M.
Where can I see AVTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AVTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Rita Jain view on EDGAR
- - Kevin Robert Lind view on EDGAR
- - Ron M. Philip view on EDGAR
- - Christopher Ryan Sullivan view on EDGAR
- - Christopher Ryan Sullivan view on EDGAR
- - Mittie Doyle view on EDGAR
- - Christopher Ryan Sullivan view on EDGAR
- - Mittie Doyle view on EDGAR
- - Jennifer Riley view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AVTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AVTX with a 7-day demo
- AVTX on your watchlist
- Every AVTX Form 4 filing on record
- Up to 3 months of AVTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
